Technology had played a vital role in the healthcare sector to improve the healthcare standards and patients experience. In vitro diagnostics (IVD) is the diagnostic solutions used by patients for detection of various diseases such as infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases in in vitro conditions. Incessant innovations in IVD product design and technological advancement have encouraged doctors and researchers to shift their focus from traditional medical methods to personalized medicines.... Research Beam Model: Research Beam Product ID: 2019228 2850 USD New
Germany IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Germany IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : September  2017
  • Pages : 140
 
 

Technology had played a vital role in the healthcare sector to improve the healthcare standards and patients experience. In vitro diagnostics (IVD) is the diagnostic solutions used by patients for detection of various diseases such as infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases in in vitro conditions. Incessant innovations in IVD product design and technological advancement have encouraged doctors and researchers to shift their focus from traditional medical methods to personalized medicines.

The Germany IVD market is majorly driven by rise in geriatric population and rapid expansion of government healthcare expenditure. In addition, increase in demand of personalized medicines and technological advancements to improve efficacy of IVD are expected to fuel the growth of the Germany IVD market. Furthermore, increase in disposable income and rise in awareness of preventive diagnosis & treatment among the population is anticipated to increase the market growth during the forecast period. However, stringent government rules and regulations is expected to hinder the growth of this market. Ongoing R&D associated to IVD is anticipated to present new opportunities for the market. The Germany IVD market is accounted for $3,727 million in 2016, and is estimated to reach at $5,453 million by 2023, growing at a CAGR of 5.5% from 2017 to 2023.

The market is segmented on the basis of product type, techniques, application, and end-user. By product type, the market is categorized into reagents, instruments, and software & services. On the basis of techniques, it is categorized into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end-user, it is categorized into hospitals, academic and medical schools, point of care testing, and others. 

KEY BENEFITS FOR SHAREHOLDERS

  •  The study provides an in-depth analysis of the Germany IVD market, with current trends and future estimations to elucidate the investment pockets.
  •  Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  •  The report provides a quantitative analysis from 2016 to 2023, which enables stakeholders to capitalize on prevailing market opportunities.
  •  Extensive analysis of different segments facilitates to understand various products of the market. 
  •  Key players are profiled and their strategies are analyzed to understand the competitive outlook of the market.

Germany IVD Market key SEGMENTS

 By Product Type

  •  Reagents 
  •  Instruments 
  •  Software and Services

 By Techniques 

  •  Immunodiagnostics
    •  Enzyme-Linked Immunosorbent Assay (ELISA)
      •  Chemiluminescence Immunoassays (CLIAS)
      •  Fluorescence Immunoassays (FIAS)
      •  Colorimetric Immunoassays (CIS)
    •  Rapid Tests
    •  Enzyme-Linked Immunospot Assays (ELISPOT) 
    •  Radioimmunoassay
    •  Western Blot
  •  Blood Testing
  •  Molecular Diagnostics
    •  Polymerase Chain Reaction (PCR)
    •  Isothermal Nucleic Acid Amplification Technology (INAAT)
    •  Hybridization
    •  DNA Diagnostics
    •  Microarrays
    •  Others
  •  Tissue Diagnostics
  •  Clinical Chemistry 
    •  Basic Metabolic Panel
    •  Liver Panel
    •  Lipid Profile
    •  Thyroid Function Panel
    •  Renal Profile
    •  Electrolyte Panel
    •  Specialty Chemicals
  •  Other IVD Techniques

 By Application 

  •  Infectious Diseases 
  •  Cancer 
  •  Cardiac Diseases 
  •  Immune System Disorders
  •  Nephrological Diseases
  •  Gastrointestinal Diseases
  •  Other Indications

 By End Users

  •  Standalone Laboratory
  •  Hospitals
  •  Academic and Medical Schools
  •  Point of Care Testing
  •  Others 

 List of players profiled in the report

  •  Thermo Fisher Scientific Inc.
  •  Alere Inc.
  •  Biomerieux 
  •  Danaher Corporation
  •  F. Hoffmann-La Roche AG
  •  Becton Dickinson and Company
  •  Bio-Rad Laboratories
  •  Bayer AG
  •  Sysmex Corporation
  •  Johnson & Johnson

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTERS FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)
5.2.4.2.1 Market size and forecast
5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 THERMO FISHER SCIENTIFIC INC.

8.1.1 Company overview
8.1.2 Business performance
8.1.3 Key strategies and development

8.2 ALERE INC.

8.2.1 Company overview
8.2.2 Business performance
8.2.3 Key strategies and developments

8.3 BIOMERIEUX

8.3.1 Company overview
8.3.2 Business performance
8.3.3 Key strategies and developments

8.4 DANAHER CORPORATION

8.4.1 Company overview
8.4.2 Business performance
8.4.3 Key strategies and development

8.5 F. HOFFMANN-LA ROCHE AG

8.5.1 Company overview
8.5.2 Business performance
8.5.3 Key strategies and developments

8.6 BECTON DICKINSON AND COMPANY

8.6.1 Company overview
8.6.2 Business performance
8.6.3 Key strategies and development

8.7 BIO-RAD LABORATORIES

8.7.1 Company overview
8.7.2 Business performance
8.7.3 Key strategies and developments

8.8 BAYER AG

8.8.1 Company overview
8.8.2 Business performance
8.8.3 Key strategies and development

8.9 SYSMEX CORPORATION

8.9.1 Company overview
8.9.2 Business performance
8.9.3 Key strategies and developments

8.10 JOHNSON & JOHNSON

8.10.1 Company overview
8.10.2 Business performance
8.10.3 Key strategies and development

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTERS FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 GERMANY CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 GERMANY FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 GERMANY COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 GERMANY RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 GERMANY ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 GERMANY WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 GERMANY POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 GERMANY ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 GERMANY HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 GERMANY DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 GERMANY MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 GERMANY OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 GERMANY BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 GERMANY LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 GERMANY RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 GERMANY LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 GERMANY THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 GERMANY ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 GERMANY SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)

List of Tables

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 GERMANY IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 GERMANY IVD REAGENTS MARKET, 2016-2023 ($MILLION)
TABLE 4 GERMANY IVD INSTRUMENTS MARKET, 2016-2023 ($MILLION)
TABLE 5 GERMANY IVD SOFTWARE & SERVICES MARKET, 2016-2023 ($MILLION)
TABLE 6 GERMANY IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 GERMANY IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 GERMANY IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 9 GERMANY IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 GERMANY IVD BLOOD TESTING TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 11 GERMANY IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 GERMANY IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 13 GERMANY IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2016-2023, ($MILLION)
TABLE 14 GERMANY IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 15 GERMANY OTHER IVD TECHNIQUES MARKET, 2016-2023, ($MILLION)
TABLE 16 GERMANY IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 GERMANY IVD INFECTIOUS DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 18 GERMANY IVD CANCER MARKET, 2016-2023 ($MILLION)
TABLE 19 GERMANY IVD CARDIAC DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 20 GERMANY IVD IMMUNE SYSTEM DISORDER MARKET, 2016-2023 ($MILLION)
TABLE 21 GERMANY IVD NEPHROLOGICAL DISEASES MARKET, 2016-2023, ($MILLION)
TABLE 22 GERMANY IVD GASTROINTESTINAL DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 23 GERMANY IVD OTHER INDICATION MARKET, 2016-2023 ($MILLION)
TABLE 24 GERMANY IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 GERMANY IVD STANDALONE LABORATORIES MARKET, 2016-2023 ($MILLION)
TABLE 26 GERMANY IVD HOSPITALS MARKET, 2016-2023 ($MILLION)
TABLE 27 GERMANY IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, 2016-2023 ($MILLION)
TABLE 28 GERMANY IVD POINT OF CARE MARKET, 2016-2023 ($MILLION)
TABLE 29 GERMANY IVD OTHER END-USER MARKET, 2016-2023 ($MILLION)
TABLE 30 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 31 ALERE INC. COMPANY SNAPSHOT
TABLE 32 BIOMERIEUX COMPANY SNAPSHOT
TABLE 33 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 34 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 35 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 36 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 37 BAYER AG COMPANY SNAPSHOT
TABLE 38 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 39 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT